Venture-backed medtechs rush for the exit
A lot of money is sloshing around, and medical device start-ups are reaping the benefits.
Medtech’s haves and have-nots
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Ortho Clinical takes a haircut
Discount pricing and poor first day defies the recent trend for floating device makers.
Medtechs rake in the venture cash
In terms of private investments, 2020 was the year of the liquid biopsy.
A beautiful autumn for Covid-19 test makers
Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.
Exact chases its dream with $1.7bn Thrive deal
Setting its sights on the screening setting, Exact aims to be a major liquid biopsy player.
Exact gatecrashes the liquid biopsy party
Preliminary data on its pan-cancer blood test appear surprisingly competitive.
Medtechs that book the most sales per employee face the greatest losses
Welcome to the calm before the Covid-19 storm.
